August #62 : Lawnmower Man - by As Told to Lark Lands

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

The Miseducation of Nushawn Williams

Smear Tactics

America's Most Unwanted

Stranger Than Fiction

The Bottom Line

Treat Your Cervix Well

Anal Alphabet

Editor's Letter

Mailbox

He The People

All My Children

NEG/POS

Skin To Skin

Say What?

Monkey Business

Calling All Dykes

Live Boys!

Cyber HIVerite

One-Man Wonders

Sound Byte

Catching Up With...

The Breakfast Club

21st-Century Fox

Across the Digital Divide

Arch Enemies

The Hole Truth

Cheap Shots

Gimme a Break!

Comfort Zone - August 2000

Lawnmower Man

Sign of the Times

Plantar’s Punch

Herb of the Month - August 2000

Crack the Combination

Damsels in De-Stress

Fire Escape



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

August 2000

Lawnmower Man

by As Told to Lark Lands

Is the grass greener after Sean Strub’s second drug holiday? Whether it revved up his immune system is too soon to tell.

The last time POZ founder Sean O. Strub dipped his toe into the choppy waters of Strategic Treatment Interruptions (STIs), the results were so bad that Virginia Cafaro, MD, warned him, “Never do this again”. But two years ago is ancient history in HIV land. With all the new talk about possible benefits of STIs (see “Gimme a Break), Sean decided to step into the same river twice. POZ Science Editor Lark Lands asked him to describe his three-week swim.

I had been reading about the potential of STIs to both stimulate the immune system’s control of HIV and offer a vacation from side effects. Luckily, I wasn’t having many problems with my HAART meds—indinavir (Crixivan), d4T (Zerit) and delavirdine (Rescriptor)—other than persistent post-dosing anxiety (caused by the Crixivan, I think). But I was curious to see whether my viral load might come back slower this time than with my first STI, possibly indicating some return of anti-HIV immune response.

I wondered whether immune response might be like starting a lawnmower in the spring after it’s sat in the garage all winter: You pull it the first time and it does nothing. The second time it sputters. The third time it runs for a moment and then stops. The fourth time, it starts going.

During my previous two-week STI, the virus came back like a freight train. In just 10 days, my viral load jumped from undetectable to over a million, and my CD4s plummeted from 357 to 154—and it took three months for my lab numbers to recover. While I was off drugs, I had severe fatigue, painfully swollen lymph glands and headaches. I felt so severely ill that I couldn’t work.

This time my viral load glided up a bit slower. After months of undetectable viral loads, I went off my meds on March 22. Within two weeks my count had crept up to 505. By three weeks it was only at 105,760. The CD4s dropped from 483 pre-STI to 306, which many consider a significant falloff, although smaller than last time.

My symptoms during this STI were greatly reduced. For the first two weeks, I felt great and my anxiety began waning. At about three weeks, I felt my lymph glands swell—most visibly in my groin—and began feeling some fatigue. I also experienced an instinctive, hard-to-describe “active virus” feeling. Interestingly, I expected viral activity slower and later than during the first STI, and that’s exactly what I got. (I don’t know how much my expectations affected the outcome.) When I resumed therapy on April 13, I was feeling the viral rebound, but nothing like the first time.

I expect to try another STI at some point. Meanwhile, I’ll keep reading up on these interesting and risky experiments. I’ve been urging PWAs to carefully document and share their experiences. As has happened before, we may point the way to promising new research.


Scroll down to comment on this story.





Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    guycmh328
    Columbus
    Ohio


    Newhopenate
    New Hope
    Pennsylvania


    Deelight4u
    BROOKLYN
    New York


    Fergie911
    Chicago
    Illinois
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you work with your doc to design your own treatment regimen?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.